Introduction
Tetrahydrocurcumin vs curcumin is a comparison the supplement industry has already decided for you. Search that phrase and you will mostly find ingredient suppliers who are selling the raw material, announcing that the reduced compound wins. Almost none of them tells you which experiments produced that verdict or in what species. I use a tetrahydrocurcuminoid extract in my own Curcumin capsule, so I have every commercial reason to repeat the claim. Instead I will show you what has actually been measured, where the two compounds split, and where the human record runs out. Read the evidence that way and a label becomes a decision you can defend.
What Is Tetrahydrocurcumin? A Closer Look
Tetrahydrocurcumin is curcumin with four hydrogen atoms added across the two double bonds in its central carbon chain. That single change does two things any chemist would predict. It strips out the color, which is why the compound is sold as a white curcumin rather than as a yellow powder. It also saturates the reactive stretch of the molecule that several of curcumin's known actions depend on. Hold on to that second point because it explains nearly everything that follows.
You do not need a supplement to encounter tetrahydrocurcumin. Your own gut bacteria manufacture it from the curcumin in turmeric. Researchers isolated curcumin-converting microorganisms from human feces and found the highest activity in Escherichia coli (Hassaninasab et al., 2011). They purified the responsible enzyme and named it NADPH-dependent curcumin and dihydrocurcumin reductase. That enzyme runs a two-step reduction, turning curcumin first into dihydrocurcumin and then into tetrahydrocurcumin.
Animal work fills in what happens next. In mice given curcumin by injection, the compound appeared in plasma largely as glucuronide conjugates (Pan et al., 1999). Treating that mouse plasma with an enzyme that cleaves those conjugates released both curcumin and tetrahydrocurcumin. The authors concluded that tetrahydrocurcumin is one of the major curcumin metabolites in mice. Those same mice carried only trace curcumin in brain tissue one hour after dosing at 0.41 micrograms per gram.
How much of that conversion happens appears to depend on the bacteria doing it. Investigators cleared the gut microbiota of Sprague-Dawley rats with an antibiotic and then measured curcumin metabolites (Luo et al., 2025). Disrupting the microbiota in those rats suppressed biotransformation into tetrahydrocurcumin and raised urinary curcumin excretion. Whether that variation holds in people has not been investigated, and I have found no study that settles it. Gut bacteria shape far more than digestion, which is the subject of my article on the gut brain connection.
Tetrahydrocurcumin vs Curcumin: What the Direct Comparisons Measured
Comparing tetrahydrocurcumin vs curcumin honestly means naming the limit before the findings. Nearly every comparison in this literature is a chemical assay, a cell-culture experiment, or a rodent study. Extraordinarily little of it involved a person swallowing either compound. I will report the results anyway, and I will name the species every time. Reading them any other way is how a test tube quietly becomes a health claim.
Stability is the first real difference, and it was measured in glassware. Curcumin in phosphate buffer at pH 7.2 and 37 degrees lost about 90 percent within 30 minutes (Wang et al., 1997). That figure came from a cell-free buffer system rather than from a person. The same study found curcumin far more durable in human blood, where under 20 percent broke down in an hour. Tetrahydrocurcumin held steady across a range of buffer pH values in cell-free testing (Pan et al., 1999).
Antioxidant capacity is the claim the ingredient suppliers lean on hardest. In cell-free radical assays, the hydrogenated derivatives of curcumin scavenged DPPH radicals more strongly than curcumin itself (Somparn et al., 2007). Tetrahydrocurcumin ranked highest of every compound tested in those assays, above curcumin and above the reference antioxidant trolox. That paper also reported stronger protection against red blood cell hemolysis for the hydrogenated derivatives in a laboratory assay. None of that is a health outcome, and the authors never presented it as one.
A second group asked the same question a separate way and got a much flatter answer. Using a cell-free polymerization assay, they counted peroxyl radicals trapped per molecule (Kadoma & Fujisawa, 2007). Curcumin scored 3.4 and tetrahydrocurcumin scored 3.3, a gap of no practical consequence. Whether tetrahydrocurcumin outperforms curcumin therefore depends on which radical you test and which method you run. Any page reporting a single assay and calling the matter settled has chosen its assay.
Two studies compared the compounds head to head in living animals, and they disagree. In mice with chemically induced colitis, curcumin reduced disease severity while tetrahydrocurcumin had much weaker inhibitory effects (Yang et al., 2018). Those authors called tetrahydrocurcumin the non-electrophilic analogue, which is precisely the reactive stretch hydrogenation removes. In diabetic mice and in human platelets stimulated with high glucose in cell culture, tetrahydrocurcumin outperformed curcumin (Hu et al., 2026). Neither compound is simply better, and the chemistry predicts exactly that split. Persistent inflammation is a further pathway I examine in inflammation and brain health.
Tetrahydrocurcumin Supplement Forms, Powder, and Standardized Extracts
Two routes exist to get tetrahydrocurcumin into your body, and only one involves buying it. The first is to eat or supplement curcumin and let your gut bacteria reduce it for you. The second is a tetrahydrocurcuminoid extract, which delivers the reduced compound without asking your microbiome to make it. Turmeric on the spice rack is a curcumin source rather than a practical tetrahydrocurcumin source. No amount of curry powder hands you a measured dose of the metabolite.
A label reading tetrahydrocurcuminoids describes a group rather than a single molecule. Curcumin, demethoxycurcumin, and bisdemethoxycurcumin each have a hydrogenated counterpart, and all three can be inside that group. The distinction matters because the demethoxy forms of curcumin showed lower antioxidant activity in cell-free assays (Somparn et al., 2007). A percentage on a bottle tells you how much of the group is present, not which members dominate it.
My own tetrahydrocurcumin supplement uses Curcumin C3 Reduct® at 95 percent tetrahydrocurcuminoids. Sabinsa produces that extract, and I name the supplier because you ought to be able to verify it. Two capsules supply an 800 milligram liposomal blend holding six ingredients in total. The other five are N-acetyl cysteine, glucosamine chondroitin, phosphatidylcholine, beta cyclodextrin, and sunflower lecithin. Beta cyclodextrin is a ring-shaped sugar (i.e., a carrier that helps poorly soluble compounds dissolve).
The rest of the panel is worth reading as carefully as the blend itself. Outside that blend sit dicalcium phosphate, dextrose, rice fiber, a rice extract blend, and a vegetable cellulose capsule. My manufacturing partner seals the actives inside a liposome drawn entirely from natural constituents, by a patent-pending method. The liposome forms as a dry powder, and that powder goes into a capsule without compression. Whether a liposome changes what reaches the bloodstream is a question I weigh against the human trials in liposomal curcumin. The formula is vegan and non-GMO, and free of gluten, dairy, wheat, soy, yeast, tree nuts, and peanuts.
One further form deserves mention, and it is not swallowed. Researchers developing a topical preparation describe tetrahydrocurcumin as white curcumin, a stable and colorless hydrogenated product (Kakkar et al., 2018). Colorlessness is a cosmetic property rather than a health finding, and I report it as exactly that.
Tetrahydrocurcumin Dosage: What the Study Doses Actually Were
No agency has ever set an intake figure for tetrahydrocurcumin, and none will ever likely do so. The compound is not an essential nutrient, so no requirement for it can exist. The literature substitutes a scatter of doses, each one tied to a particular experiment. Most of those experiments were conducted in rodents, which makes the numbers far less portable than they look.
The rodent doses are large and expressed in a unit no label uses. A 90-day study gave Wistar rats 100, 200, and 400 milligrams per kilogram of body weight daily (Majeed et al., 2019). A platelet study fed diabetic mice tetrahydrocurcumin at 800 milligrams per kilogram of diet for four weeks (Hu et al., 2026). A colitis study gave mice 0.1 or 0.25 millimoles per kilogram of body weight daily (Yang et al., 2018). Converting any of those into a human serving requires assumptions I am not willing to make in public.
Three human studies used amounts small enough to recognize from a bottle. An open-label pilot gave 100 milligrams of tetrahydrocurcuminoids twice daily to 60 patients with canker sore or gingivitis (Majeed et al., 2020). That study ran up to 21 days and carried no control group at all. A randomized pilot gave 200 milligrams daily for 29 days to adults with major depressive disorder, alongside their standard medication (Guo et al., 2025). A preliminary randomized study applied a tetrahydrocurcuminoid cream to 10 subjects with vitiligo, alongside phototherapy (Asawanonda & Klahan, 2010). The canker sore and gingivitis pilot was authored by scientists at the company that manufactures the ingredient.
My own label lists a serving as two capsules, and a bottle of sixty covers thirty days. Those two capsules carry 800 milligrams of a liposomal proprietary blend. A proprietary blend discloses the total and withholds the amounts inside it, which is what mine does. Six ingredients share that 800 milligrams, so the tetrahydrocurcuminoid content is an unstated fraction of it. I cannot tell you how my serving compares with the 200 milligrams used in the two oral human studies.
That limit is a choice my own company made. Nobody outside the company can check my serving against a trial dose while the panel reads that way. I would rather write that sentence than let a blend figure pass for a dose figure. Reading any tetrahydrocurcumin dosage claim, ask what the standardization is, what the blend conceals, and whether a certificate of analysis exists. Work out your own amount with a qualified clinician who knows what else you take.
Tetrahydrocurcumin Side Effects and What the Safety Record Covers
The formal safety work on tetrahydrocurcumin is preclinical, and its boundaries are worth knowing exactly. Investigators gave Wistar rats 100, 200, or 400 milligrams per kilogram daily for 90 days (Majeed et al., 2019). They ran a reproductive and developmental study in adult male and female rats at the same three doses. Those rats showed no significant treatment effect on the measured parameters, and the authors set a no-observed-adverse-effect level of 400 milligrams per kilogram daily. A rodent no-effect level opens a safety assessment rather than closing one.
Who ran that rat study matters, and I would rather tell you than let you discover it. The 90-day work was conducted at Sami Labs, part of the Sami-Sabinsa group. Sabinsa supplies the Curcumin C3 Reduct® extract in my own capsule, so the safety anchor for this ingredient comes from its manufacturer. The one oral human pilot study of the ingredient carries that same corporate affiliation. Supplier-funded research is not automatically wrong, and it is also not independent, and you deserve both facts.
A second feature of this literature earns your skepticism. Two papers on tetrahydrocurcumin were retracted during 2026, both of them animal or cell studies. One 2026 notice retracting an animal study cites image duplication and overlap with an earlier paper (Neuroimmunomodulation, 2026). A field still assembling its evidence base is a field where retractions land hard. I would rather build on the studies that survive that process than on the ones that do not.
Anyone weighing a curcuminoid product should also know the liver question hanging over the wider category. Reviewers at the United States Pharmacopeia examined reports of hepatotoxicity tied to turmeric and curcuminoid supplements (Akhtar et al., 2026). Their review covers turmeric and curcuminoids broadly rather than tetrahydrocurcumin specifically, so that is important to know. Both compounds curbed platelet activation in diabetic mice and in human platelets stimulated with high glucose in cell culture (Hu et al., 2026). Anyone on blood-thinning medication should put that finding in front of the prescribing physician. Pregnancy and nursing warrant the same conversation before anything new enters the cabinet.
Tetrahydrocurcumin vs Curcumin: How I Read the Comparison
Everything above reduces tetrahydrocurcumin versus curcumin to one uncomfortable sentence. The human evidence on this compound amounts to three small studies, each of them in a patient population. The only randomized trial with blinded raters enrolled 19 adults with major depressive disorder (Guo et al., 2025). Total depression scores in those adults showed no significant difference between the groups. In the 10 subjects with vitiligo, the difference between the combination and phototherapy alone did not reach significance either (Asawanonda & Klahan, 2010). Searching the literature turned up no human pharmacokinetic study of the compound itself, in any formulation.
A review of this compound says much the same thing in its own words. Its authors state that only limited pharmacokinetic and oral bioavailability studies have been performed on tetrahydrocurcumin (Lai et al., 2020). A more recent review describes the compound as carrying higher bioavailability and stability than curcumin (Zhou et al., 2024). Both statements can hold at once, and only one of them rests on measurement in people. Naming a gap in my own evidence is a habit that also runs through best supplements for memory loss.
Four statements sit within easy reach on this subject, and I am refusing every one. Saying the reduced compound beats curcumin would ignore two animal comparisons pointing opposite ways. Moving a milligram-per-kilogram rodent dose onto a human label would be inventing a number. Calling a cell-free antioxidant ranking a health outcome would confuse a beaker with a body. Quoting supplier-funded research without naming the funder would hide the fact you most need. Printing my 800 milligram blend figure as though it were a dose would be the same trick in another costume.
Having said all of that, I still chose the reduced compound, and my reasons are formulation reasons. Tetrahydrocurcumin held up across buffer pH values where curcumin did not, which matters for a product sitting on a shelf (Pan et al., 1999). The compound is also what your own gut bacteria make from curcumin, so a capsule introduces nothing foreign. Why N-acetyl cysteine is included in the same formula is a separate discussion about glutathione. None of those reasons is an outcome claim, and I refuse to dress them up as one.
What I do every day weighs more here than any molecule on a label. I have eaten a whole-food, plant-based diet since 1999, and turmeric has been a part of my diet for many years. Decades of drug-free, high-intensity bodybuilding have taught me to distrust a claim with no trial behind it. My own published clinical research tested Daily Brain Care, and those trials concern polysaccharides rather than curcuminoids. The About page carries that record, and this article deserves to be weighed against it.
Conclusion
Tetrahydrocurcumin versus curcumin is a real comparison resting on a thin human record. The reduced compound proved more stable in glassware and ranked higher in cell-free radical assays. It also lost to curcumin in one mouse study and beat it in another. No published pharmacokinetic study of the compound in people appears to exist. Weigh a label against that record and the premium stops being an act of faith. Order our Curcumin today if tetrahydrocurcuminoids are what you are after.
Frequently Asked Questions
What is tetrahydrocurcumin?
Tetrahydrocurcumin is curcumin with four hydrogen atoms added across the two double bonds in its central chain. Losing those bonds removes the yellow color, which is why suppliers call it white curcumin. Your own gut bacteria produce the same compound from curcumin, using a reductase enzyme first purified from Escherichia coli (Hassaninasab et al., 2011).
What is the difference in tetrahydrocurcumin vs curcumin?
Chemically, hydrogenation saturates the reactive stretch of curcumin and leaves the phenolic groups intact. Practically, tetrahydrocurcumin stayed more stable across buffer pH values than curcumin in cell-free testing (Pan et al., 1999). Biologically, the two compounds split by model. Curcumin was the stronger of the pair in mice with chemically induced colitis (Yang et al., 2018). Tetrahydrocurcumin was stronger in diabetic mice and in human platelets in cell culture (Hu et al., 2026).
What is tetrahydrocurcumin good for?
Researchers have mostly studied tetrahydrocurcumin in chemical assays, cultured cells, and rodents. In cell-free radical assays it scavenged DPPH more strongly than curcumin and than the reference antioxidant trolox (Somparn et al., 2007). Human work remains limited to three small studies, each conducted in a patient population. None of that supports a claim about treating, preventing, or managing any condition, and I make none.
How much tetrahydrocurcumin should you take?
Tetrahydrocurcumin is not an essential nutrient, so no intake figure has ever been set for it. Two studies in patient populations used 100 milligrams twice daily and 200 milligrams daily (Majeed et al., 2020; Guo et al., 2025). Those trials ran 21 and 29 days, respectively. My own capsule is built on an extract at 95 percent tetrahydrocurcuminoids, served as two capsules. Those two capsules hold an 800 milligram proprietary blend of six ingredients, and the panel does not break out the amounts. Decide your own amount with a qualified clinician who knows what else you take.
Is tetrahydrocurcumin bad for you?
A 90-day study in Wistar rats set a no-observed-adverse-effect level of 400 milligrams per kilogram daily (Majeed et al., 2019). A reproductive study in rats at the same three doses found no significant effect. That study was conducted at the company that supplies the ingredient, which you should weigh. United States Pharmacopeia reviewers examined hepatotoxicity reports across turmeric and curcuminoid supplements as a category (Akhtar et al., 2026). Anyone on blood-thinning medication, and anyone pregnant or nursing, should consult a physician first.
References
Akhtar, N., Barnes, J., Gardiner, P., Gurley, B. J., Ko, R., Koturbash, I., Patel, D., van Breemen, R. B., & Roe, A. L. (2026). Rarely reported cases of hepatotoxicity associated with turmeric- and curcuminoid-containing dietary supplements: A comprehensive review by USP. Pharmaceutical Biology, 64(1), 866–901. https://doi.org/10.1080/13880209.2026.2693375
Asawanonda, P., & Klahan, S. O. (2010). Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: A preliminary randomized controlled study. Photomedicine and Laser Surgery, 28, 679–684. https://doi.org/10.1089/pho.2009.2637
Guo, Y., Xie, J., Luo, H., Yuan, Y., Long, F., Meng, J., Tan, H., Li, Y., Cai, B., Chen, M., Yang, L., Zhong, J., Zhu, Y., & Shao, H. (2025). Tetrahydrocurcumin for major depressive disorder with therapeutic potential and mechanistic insights from clinical and preclinical studies. Molecular Neurobiology, 63(1), 323. https://doi.org/10.1007/s12035-025-05627-5
Hassaninasab, A., Hashimoto, Y., Tomita-Yokotani, K., & Kobayashi, M. (2011). Discovery of the curcumin metabolic pathway involving a unique enzyme in an intestinal microorganism. Proceedings of the National Academy of Sciences, 108(16), 6615–6620. https://doi.org/10.1073/pnas.1016217108
Hu, J., Bi, X., Zhang, C., Zhao, X., Zhang, X., Li, M., Ma, J., Li, R., Chen, B., Jiang, Y., Gao, Q., & Ya, F. (2026). Comparative efficacy of curcumin and its metabolite tetrahydrocurcumin in attenuating diabetic platelet hyperreactivity by suppressing integrin αIIbβ3 activation via an oxidative stress-dependent pathway. Journal of Agricultural and Food Chemistry, 74(4), 3655–3668. https://doi.org/10.1021/acs.jafc.5c12711
Kadoma, Y., & Fujisawa, S. (2007). Comparative radical-scavenging activity of curcumin and tetrahydrocurcumin with thiols as measured by the induction period method. In Vivo, 21(6), 979–982. https://pubmed.ncbi.nlm.nih.gov/18210744/
Kakkar, V., Kaur, I. P., Kaur, A. P., Saini, K., & Singh, K. K. (2018). Topical delivery of tetrahydrocurcumin lipid nanoparticles effectively inhibits skin inflammation: In vitro and in vivo study. Drug Development and Industrial Pharmacy, 44(10), 1701–1712. https://doi.org/10.1080/03639045.2018.1492607
Lai, C. S., Ho, C. T., & Pan, M. H. (2020). The cancer chemopreventive and therapeutic potential of tetrahydrocurcumin. Biomolecules, 10(6), 831. https://doi.org/10.3390/biom10060831
Luo, F., Chen, J., Liang, S., Wang, X., Chai, X., Zheng, Z., Zhu, D., & Guo, L. (2025). In vivo investigation on the effect of gut microbiota on the distribution and biotransformation of curcumin. Journal of Agricultural and Food Chemistry, 73(41), 26206–26219. https://doi.org/10.1021/acs.jafc.5c09992
Majeed, M., Majeed, S., & Nagabhushanam, K. (2020). Efficacy and safety of tetrahydrocurcuminoids for the treatment of canker sore and gingivitis. Evidence-Based Complementary and Alternative Medicine, 2020, 6611877. https://doi.org/10.1155/2020/6611877
Majeed, M., Natarajan, S., Pandey, A., Bani, S., & Mundkur, L. (2019). Subchronic and reproductive/developmental toxicity studies of tetrahydrocurcumin in rats. Toxicological Research, 35(1), 65–74. https://doi.org/10.5487/tr.2019.35.1.065
Neuroimmunomodulation. (2026). Retraction statement: Tetrahydrocurcumin provides neuroprotection in experimental traumatic brain injury and the Nrf2 signaling pathway as a potential mechanism. Neuroimmunomodulation, 33(1), 336–337. https://pubmed.ncbi.nlm.nih.gov/42726676/
Pan, M. H., Huang, T. M., & Lin, J. K. (1999). Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metabolism and Disposition, 27(4), 486–494. https://doi.org/10.1016/s0090-9556(24)15211-7
Somparn, P., Phisalaphong, C., Nakornchai, S., Unchern, S., & Morales, N. P. (2007). Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives. Biological and Pharmaceutical Bulletin, 30(1), 74–78. https://doi.org/10.1248/bpb.30.74
Wang, Y. J., Pan, M. H., Cheng, A. L., Lin, L. I., Ho, Y. S., Hsieh, C. Y., & Lin, J. K. (1997). Stability of curcumin in buffer solutions and characterization of its degradation products. Journal of Pharmaceutical and Biomedical Analysis, 15(12), 1867–1876. https://doi.org/10.1016/s0731-7085(96)02024-9
Yang, J. Y., Zhong, X., Kim, S. J., Kim, D. H., Kim, H. S., Lee, J. S., Yum, H. W., Lee, J., Na, H. K., & Surh, Y. J. (2018). Comparative effects of curcumin and tetrahydrocurcumin on dextran sulfate sodium-induced colitis and inflammatory signaling in mice. Journal of Cancer Prevention, 23(1), 18–24. https://doi.org/10.15430/jcp.2018.23.1.18
Zhou, M., Li, R., Hua, H., Dai, Y., Yin, Z., Li, L., Zeng, J., Yang, M., Zhao, J., & Tan, R. (2024). The role of tetrahydrocurcumin in disease prevention and treatment. Food & Function, 15(13), 6798–6824. https://doi.org/10.1039/d3fo05739a
